Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
A legfontosabb adatok
- Ki végzi
- Medical College of Wisconsin
- Hol
- Milwaukee (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 90 fő, tervezett
- Kezdés
- 2021. ápr. 5.
- Várható befejezés
- 2026. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Percutaneous vagal nerve stimulation (pVNS) device
- Acoustic vagal nerve stimulation (aVNS) treatment
- A regiszteradat frissítve
- 2026. február 13.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for children aged 10 to 18 with upper stomach or gut complaints. They must also have suspected hypermobile Ehlers-Danlos syndrome (hEDS), a related joint hypermobility disorder (HSD), or a problem with the nervous system that controls automatic body functions.
- Életkor
- 10 to 18 years
- Nem
- All
- A betegség stádiuma
- Functional upper GI complaints (no damage or disease found to explain them). Also a clinical suspicion of hEDS or HSD with a Beighton score of at least 4/9, or a suspected problem with the automatic nervous system (ANS dysfunction). No other explanation for the symptoms.
- Korábbi kezelés
- Cannot join if a new drug that affects the brain or nerves was started in the 2 weeks before enrolment.
- Biomarker vagy leletérték
- Beighton score (a joint flexibility test) of at least 4/9 for the hEDS or HSD group.
A részvétel fő kizáró okai
- Complex medical problems, or a disease or medicine that could explain the symptoms
- Other gut diseases, such as peptic ulcer, H.pylori gastritis, celiac disease, inflammatory bowel disease, allergic or metabolic disorders
- Significant developmental delay
- Pregnancy
- Long-term alcohol or illegal drug use, or smoking
A regiszter feltételei, szó szerint
Mind a 32 feltétel megnézéseKevesebb
Ki vehet részt
- Children aged 10-18 years old
- Children with functional upper GI complaints and clinical suspicion for hEDS or HSD as well as a Beighton score of at least 4/9
- Children with functional upper GI complaints and clinical suspicion for ANS dysfunction
- De-identified data from our prior studies (IRB #689519 and IRB #1064187) of patients with functional GI disorders who do NOT meet criteria for hEDS will be used as a comparison group
- Children who are English-speaking and lack other explanation for symptoms
- Children willing to participate and consent to this study (for children, have a parent willing to participate)
Ki nem vehet részt
- Patients who are treated with a new drug affecting the central nervous system in the two weeks prior to enrollment will also be excluded
- Chronic alcohol/illicit drug use and/or smoking
- Exclusion Criteria for subjects undergoing pVNS therapy:
- Exclusion Criteria for subjects undergoing aVNS therapy:
- Patients with pacemakers, metal clips used in previous surgery or other device which are not compatible with MRI scanning
- Medically complex children or those who take a medication or suffer from a disease that can explain symptoms will be excluded from participation in the study
- Patients with findings of organic disease such as peptic ulcer disease, H.pylori gastritis, celiac disease, inflammatory bowel disease, allergic disorders, metabolic disorder or any other chronic condition or medication that may cause chronic GI symptoms will be excluded from the study
- Severe dermatological condition or active infection of external or middle ear
- Seizure disorder
- Egg allergy or anticipated inability to complete a standardized egg meal
- Bleeding disorder for the specific biopsies
- Exclusion Criteria applying to all participants:
- Adult subjects, children or their parents who have significant developmental delay (will be excluded due to difficulties in accurately completing the questionnaires and assessing symptoms)
- Pregnancy (evaluating MD screens patients as they normally would during a clinic visit (by questioning) and would only perform urine pregnancy test if clinically indicated (absence of menstrual period or other symptoms concerning for pregnancy)
- Implanted electrical device
- Hearing impaired
- Sight impaired without correction
- Exclusion Criteria for subjects undergoing gastric motor function sub-study:
- Claustrophobia or inability to lie still in the scanner
- Orthodontic braces or permanent retainers
- Patients who are unable to tolerate noise produced by the MRI
- Exclusion Criteria for subjects undergoing HepGI Biobank specimen collection sub-study:
- Recent antibiotic usage for fecal sample
- Significant anemia or clinical status which will not allow safe blood draw required for blood collection
- Refusal of blood collection or to provide DNA sample
- Inability or unwillingness on the individual (or parent/legal guardian) to provide clinical or family history
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 10 és 18 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- Medical College of WisconsinMilwaukee, Egyesült ÁllamokContact: Elaina Schueler, BARésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Hypermobile Ehlers-Danlos Syndrome (hEDS) is a connective tissue disorder characterized by hyperextensible skin, joint hypermobility and additional connective tissue manifestations. For unclear reasons, hEDS is associated with many gastrointestinal (GI) and autonomic nervous system (ANS) complaints such as postural orthostatic tachycardia syndrome (POTS). This study will address the clinical relationship between hEDS/Hypermobile Spectrum Disorders and autonomic regulation and see if there is a benefit of two forms of non-invasive vagal nerve stimulation therapies to reduce GI symptoms in hEDS and POTS. The study will also investigate plausible effects of these nerve stimulation therapies on gastric function and autonomic signaling.
A vizsgálat 2 csoportja
- Treatment Arm A (hEDS)Már használt kezelés, összehasonlításként
(n=60) patients who meet criteria for hEDS or Hypermobile Spectrum Disorder (HSD) will receive aVNS (acoustic vagal nerve stimulation) therapy via filtered vocal music sound therapy using the Safe and Sound protocol (randomized 1:1 to active vs sham music; double blind study design)
Kezelés: Acoustic vagal nerve stimulation (aVNS) treatment
- Treatment Arm B (ANS Dysfunction)A vizsgált kezelés
(n=30) patients with concerns for ANS dysfunction (with or without hEDS) will receive auricular percutaneous vagal nerve stimulation (pVNS) therapy. Additional sub-study option: 15-20 subjects will undergo gastric MRI and (those who consent to it) will also participate in a biobank blood sample collection study.
Kezelés: Percutaneous vagal nerve stimulation (pVNS) device
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Hypermobile Ehlers-Danlos Syndrome: Efficacy of Non-invasive Vagal Nerve Stimulation and Effects on Brain-Gut Physiology
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT05212129: ki vehet részt
- A regiszteradat frissítve
- 2026. február 13.